ArticleCancer medicine2021

The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.

Massimiliano Bonifacio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.